▶ 調査レポート

世界の末梢神経障害の治療市場:市場規模・現状・予測

• 英文タイトル:Global Peripheral Neuropathy Treatment Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の末梢神経障害の治療市場:市場規模・現状・予測 / Global Peripheral Neuropathy Treatment Market Size, Status and Forecast 2019-2025 / QYR9N7794資料のイメージです。• レポートコード:QYR9N7794
• 出版社/出版日:QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、92ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当資料は、末梢神経障害の治療のグローバル市場について調査・分析したレポートで、種類別(カルシウムチャンネルα2 - デルタ配位子、抗うつ薬、オピオイド、その他)、用途別(プラチナエージェント、タキサン、ビンカアルカロイド、その他)、主要地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米)の市場規模、市場予測、関連企業情報などが含まれています。

・末梢神経障害の治療の世界市場規模
・主要企業別市場シェア
・末梢神経障害の治療の世界市場規模:種類別(カルシウムチャンネルα2 - デルタ配位子、抗うつ薬、オピオイド、その他)
・末梢神経障害の治療の世界市場規模:用途別(プラチナエージェント、タキサン、ビンカアルカロイド、その他)
・末梢神経障害の治療のアメリカ市場規模(種類別、用途別)
・末梢神経障害の治療のヨーロッパ市場規模(種類別、用途別)
・末梢神経障害の治療の中国市場規模(種類別、用途別)
・末梢神経障害の治療の日本市場規模(種類別、用途別)
・末梢神経障害の治療の東南アジア市場規模(種類別、用途別)
・末梢神経障害の治療のインド市場規模(種類別、用途別)
・末梢神経障害の治療の中南米市場規模(種類別、用途別)
・主要企業別分析(企業概要、製品動向、販売量など)
・末梢神経障害の治療の世界市場予測(2019年-2025年)
・末梢神経障害の治療の地域別市場予測(2019年-2025年)
...

Peripheral neuropathy is a set of symptoms caused by any damage to the nerves that are away from the brain and spinal cord. Peripheral neuropathy is not a single, homogenous disease, but it is a mix of different clinical presentations, natural histories, and pathology.In 2018, the global Peripheral Neuropathy Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Peripheral Neuropathy Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Peripheral Neuropathy Treatment development in United States, Europe and China.

The key players covered in this study
Eli Lilly
Johnson & Johnson
Novartis
Pfizer
Aptinyx
Regenacy Pharmaceuticals
TEVA Pharmaceutical Industries
Immune Pharmaceuticals

Market segment by Type, the product can be split into
Calcium Channel α2-delta Ligands
Antidepressants
Opioids
Others

Market segment by Application, split into
Platinum Agents
Taxanes
Vinca Alkaloids
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Peripheral Neuropathy Treatment status, future forecast, growth opportunity, key market and key players.
To present the Peripheral Neuropathy Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Peripheral Neuropathy Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Peripheral Neuropathy Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Calcium Channel α2-delta Ligands
1.4.3 Antidepressants
1.4.4 Opioids
1.4.5 Others
1.5 Market by Application
1.5.1 Global Peripheral Neuropathy Treatment Market Share by Application (2014-2025)
1.5.2 Platinum Agents
1.5.3 Taxanes
1.5.4 Vinca Alkaloids
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Peripheral Neuropathy Treatment Market Size
2.2 Peripheral Neuropathy Treatment Growth Trends by Regions
2.2.1 Peripheral Neuropathy Treatment Market Size by Regions (2014-2025)
2.2.2 Peripheral Neuropathy Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Peripheral Neuropathy Treatment Market Size by Manufacturers
3.1.1 Global Peripheral Neuropathy Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Peripheral Neuropathy Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Peripheral Neuropathy Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Peripheral Neuropathy Treatment Key Players Head office and Area Served
3.3 Key Players Peripheral Neuropathy Treatment Product/Solution/Service
3.4 Date of Enter into Peripheral Neuropathy Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Peripheral Neuropathy Treatment Market Size by Type (2014-2019)
4.2 Global Peripheral Neuropathy Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Peripheral Neuropathy Treatment Market Size (2014-2019)
5.2 Peripheral Neuropathy Treatment Key Players in United States
5.3 United States Peripheral Neuropathy Treatment Market Size by Type
5.4 United States Peripheral Neuropathy Treatment Market Size by Application

6 Europe
6.1 Europe Peripheral Neuropathy Treatment Market Size (2014-2019)
6.2 Peripheral Neuropathy Treatment Key Players in Europe
6.3 Europe Peripheral Neuropathy Treatment Market Size by Type
6.4 Europe Peripheral Neuropathy Treatment Market Size by Application

7 China
7.1 China Peripheral Neuropathy Treatment Market Size (2014-2019)
7.2 Peripheral Neuropathy Treatment Key Players in China
7.3 China Peripheral Neuropathy Treatment Market Size by Type
7.4 China Peripheral Neuropathy Treatment Market Size by Application

8 Japan
8.1 Japan Peripheral Neuropathy Treatment Market Size (2014-2019)
8.2 Peripheral Neuropathy Treatment Key Players in Japan
8.3 Japan Peripheral Neuropathy Treatment Market Size by Type
8.4 Japan Peripheral Neuropathy Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Peripheral Neuropathy Treatment Market Size (2014-2019)
9.2 Peripheral Neuropathy Treatment Key Players in Southeast Asia
9.3 Southeast Asia Peripheral Neuropathy Treatment Market Size by Type
9.4 Southeast Asia Peripheral Neuropathy Treatment Market Size by Application

10 India
10.1 India Peripheral Neuropathy Treatment Market Size (2014-2019)
10.2 Peripheral Neuropathy Treatment Key Players in India
10.3 India Peripheral Neuropathy Treatment Market Size by Type
10.4 India Peripheral Neuropathy Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Peripheral Neuropathy Treatment Market Size (2014-2019)
11.2 Peripheral Neuropathy Treatment Key Players in Central & South America
11.3 Central & South America Peripheral Neuropathy Treatment Market Size by Type
11.4 Central & South America Peripheral Neuropathy Treatment Market Size by Application

12 International Players Profiles
12.1 Eli Lilly
12.1.1 Eli Lilly Company Details
12.1.2 Company Description and Business Overview
12.1.3 Peripheral Neuropathy Treatment Introduction
12.1.4 Eli Lilly Revenue in Peripheral Neuropathy Treatment Business (2014-2019)
12.1.5 Eli Lilly Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Peripheral Neuropathy Treatment Introduction
12.2.4 Johnson & Johnson Revenue in Peripheral Neuropathy Treatment Business (2014-2019)
12.2.5 Johnson & Johnson Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Peripheral Neuropathy Treatment Introduction
12.3.4 Novartis Revenue in Peripheral Neuropathy Treatment Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Peripheral Neuropathy Treatment Introduction
12.4.4 Pfizer Revenue in Peripheral Neuropathy Treatment Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Aptinyx
12.5.1 Aptinyx Company Details
12.5.2 Company Description and Business Overview
12.5.3 Peripheral Neuropathy Treatment Introduction
12.5.4 Aptinyx Revenue in Peripheral Neuropathy Treatment Business (2014-2019)
12.5.5 Aptinyx Recent Development
12.6 Regenacy Pharmaceuticals
12.6.1 Regenacy Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Peripheral Neuropathy Treatment Introduction
12.6.4 Regenacy Pharmaceuticals Revenue in Peripheral Neuropathy Treatment Business (2014-2019)
12.6.5 Regenacy Pharmaceuticals Recent Development
12.7 TEVA Pharmaceutical Industries
12.7.1 TEVA Pharmaceutical Industries Company Details
12.7.2 Company Description and Business Overview
12.7.3 Peripheral Neuropathy Treatment Introduction
12.7.4 TEVA Pharmaceutical Industries Revenue in Peripheral Neuropathy Treatment Business (2014-2019)
12.7.5 TEVA Pharmaceutical Industries Recent Development
12.8 Immune Pharmaceuticals
12.8.1 Immune Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Peripheral Neuropathy Treatment Introduction
12.8.4 Immune Pharmaceuticals Revenue in Peripheral Neuropathy Treatment Business (2014-2019)
12.8.5 Immune Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Peripheral Neuropathy Treatment Key Market Segments
Table Key Players Peripheral Neuropathy Treatment Covered
Table Global Peripheral Neuropathy Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Peripheral Neuropathy Treatment Market Size Market Share by Type 2014-2025
Figure Calcium Channel α2-delta Ligands Figures
Table Key Players of Calcium Channel α2-delta Ligands
Figure Antidepressants Figures
Table Key Players of Antidepressants
Figure Opioids Figures
Table Key Players of Opioids
Figure Others Figures
Table Key Players of Others
Table Global Peripheral Neuropathy Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Platinum Agents Case Studies
Figure Taxanes Case Studies
Figure Vinca Alkaloids Case Studies
Figure Others Case Studies
Figure Peripheral Neuropathy Treatment Report Years Considered
Table Global Peripheral Neuropathy Treatment Market Size 2014-2025 (Million US$)
Figure Global Peripheral Neuropathy Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Peripheral Neuropathy Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Peripheral Neuropathy Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Peripheral Neuropathy Treatment Market Share by Regions 2014-2019
Figure Global Peripheral Neuropathy Treatment Market Share by Regions 2014-2019
Figure Global Peripheral Neuropathy Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Peripheral Neuropathy Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Peripheral Neuropathy Treatment Market Share by Manufacturers (2014-2019)
Figure Global Peripheral Neuropathy Treatment Market Share by Manufacturers in 2018
Table Global Peripheral Neuropathy Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Peripheral Neuropathy Treatment Product/Solution/Service
Table Date of Enter into Peripheral Neuropathy Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Peripheral Neuropathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Peripheral Neuropathy Treatment Market Size Share by Type (2014-2019)
Figure Global Peripheral Neuropathy Treatment Market Size Market Share by Type (2014-2019)
Table Global Peripheral Neuropathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Peripheral Neuropathy Treatment Market Size Share by Application (2014-2019)
Figure Global Peripheral Neuropathy Treatment Market Size Market Share by Application (2014-2019)
Figure Global Peripheral Neuropathy Treatment Revenue Market Share by Application in 2018
Figure United States Peripheral Neuropathy Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Peripheral Neuropathy Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Peripheral Neuropathy Treatment Market Share (2018-2019)
Table United States Peripheral Neuropathy Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Peripheral Neuropathy Treatment Market Share by Type (2014-2019)
Table United States Peripheral Neuropathy Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Peripheral Neuropathy Treatment Market Share by Application (2014-2019)
Figure Europe Peripheral Neuropathy Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Peripheral Neuropathy Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Peripheral Neuropathy Treatment Market Share (2018-2019)
Table Europe Peripheral Neuropathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Peripheral Neuropathy Treatment Market Share by Type (2014-2019)
Table Europe Peripheral Neuropathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Peripheral Neuropathy Treatment Market Share by Application (2014-2019)
Figure China Peripheral Neuropathy Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Peripheral Neuropathy Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Peripheral Neuropathy Treatment Market Share (2018-2019)
Table China Peripheral Neuropathy Treatment Market Size by Type (2014-20189) (Million US$)
Table China Peripheral Neuropathy Treatment Market Share by Type (2014-2019)
Table China Peripheral Neuropathy Treatment Market Size by Application (2014-2019) (Million US$)
Table China Peripheral Neuropathy Treatment Market Share by Application (2014-2019)
Figure Japan Peripheral Neuropathy Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Peripheral Neuropathy Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Peripheral Neuropathy Treatment Market Share (2018-2019)
Table Japan Peripheral Neuropathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Peripheral Neuropathy Treatment Market Share by Type (2014-2019)
Table Japan Peripheral Neuropathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Peripheral Neuropathy Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Peripheral Neuropathy Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Peripheral Neuropathy Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Peripheral Neuropathy Treatment Market Share (2018-2019)
Table Southeast Asia Peripheral Neuropathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Peripheral Neuropathy Treatment Market Share by Type (2014-2019)
Table Southeast Asia Peripheral Neuropathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Peripheral Neuropathy Treatment Market Share by Application (2014-2019)
Figure India Peripheral Neuropathy Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Peripheral Neuropathy Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Peripheral Neuropathy Treatment Market Share (2018-2019)
Table India Peripheral Neuropathy Treatment Market Size by Type (2014-2019) (Million US$)
Table India Peripheral Neuropathy Treatment Market Share by Type (2014-2019)
Table India Peripheral Neuropathy Treatment Market Size by Application (2014-2019) (Million US$)
Table India Peripheral Neuropathy Treatment Market Share by Application (2014-2019)
Figure Central & South America Peripheral Neuropathy Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Peripheral Neuropathy Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Peripheral Neuropathy Treatment Market Share (2018-2019)
Table Central & South America Peripheral Neuropathy Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Peripheral Neuropathy Treatment Market Share by Type (2014-2019)
Table Central & South America Peripheral Neuropathy Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Peripheral Neuropathy Treatment Market Share by Application (2014-2019)
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Peripheral Neuropathy Treatment Business (2014-2019) (Million US$)
Figure Eli Lilly Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2014-2019)
Table Eli Lilly Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Peripheral Neuropathy Treatment Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Novartis Company Details
Table Novartis Revenue in Peripheral Neuropathy Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Peripheral Neuropathy Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Aptinyx Company Details
Table Aptinyx Revenue in Peripheral Neuropathy Treatment Business (2014-2019)(Million US$)
Figure Aptinyx Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2014-2019)
Table Aptinyx Recent Development
Table Regenacy Pharmaceuticals Company Details
Table Regenacy Pharmaceuticals Revenue in Peripheral Neuropathy Treatment Business (2014-2019)(Million US$)
Figure Regenacy Pharmaceuticals Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2014-2019)
Table Regenacy Pharmaceuticals Recent Development
Table TEVA Pharmaceutical Industries Company Details
Table TEVA Pharmaceutical Industries Revenue in Peripheral Neuropathy Treatment Business (2014-2019)(Million US$)
Figure TEVA Pharmaceutical Industries Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2014-2019)
Table TEVA Pharmaceutical Industries Recent Development
Table Immune Pharmaceuticals Company Details
Table Immune Pharmaceuticals Revenue in Peripheral Neuropathy Treatment Business (2014-2019)(Million US$)
Figure Immune Pharmaceuticals Revenue Growth Rate in Peripheral Neuropathy Treatment Business (2014-2019)
Table Immune Pharmaceuticals Recent Development
Table Global Peripheral Neuropathy Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Peripheral Neuropathy Treatment Market Size Share by Regions (2019-2025)
Figure Global Peripheral Neuropathy Treatment Market Size Share by Regions in 2025
Figure United States Peripheral Neuropathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Peripheral Neuropathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Peripheral Neuropathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Peripheral Neuropathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Peripheral Neuropathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Peripheral Neuropathy Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Peripheral Neuropathy Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Peripheral Neuropathy Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Peripheral Neuropathy Treatment Market Size by Product (2019-2025)
Figure Global Peripheral Neuropathy Treatment Market Size by Product in 2025
Table Global Peripheral Neuropathy Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Peripheral Neuropathy Treatment Market Size by Application (2019-2025)
Figure Global Peripheral Neuropathy Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources